OverviewSuggest Edit

Solutions with you in mind. At Almirall, we dedicate ourselves to finding real solutions for real needs. Our mission is to provide valuable medicines and medical devices to you and future generations. To do this, we complement our extensive research and development programme with a strategic partner network, while remaining firmly connected to all those whose lives we touch.
TypePublic
Founded1943
HQBarcelona, ES
Websitealmirall.com

Latest Updates

Employees (est.) (Sept 2020)1,773(-3%)
Share Price (Sept 2020)€9.6
Cybersecurity ratingCMore

Key People/Management at Almirall

Antonio Gallardo

Antonio Gallardo

Director, Secretary
Alfredo Barón de Juan

Alfredo Barón de Juan

Executive Vice-President, Global Commercial Operations
Gerhard Mayr

Gerhard Mayr

Chairman
Bhushan Hardas

Bhushan Hardas

Executive Vice-President R&D and Chief Scientific Officer
Karin Louise Dorrepaal

Karin Louise Dorrepaal

Independent Director
Eloi Crespo Cervera

Eloi Crespo Cervera

Vice-President, Manufacturing & Technical Services
Show more

Almirall Office Locations

Almirall has an office in Barcelona
Barcelona, ES (HQ)
151 Ronda del General Mitre
Show all (1)

Almirall Financials and Metrics

Almirall Revenue

Market capitalization (22-Sept-2020)

1.7b

Closing stock price (22-Sept-2020)

9.6
Almirall's current market capitalization is €1.7 b.
Show all financial metrics

Almirall Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

Almirall Online and Social Media Presence

Embed Graph

Almirall News and Updates

Almirall insta a innovar en colaboración para avanzar en los nuevos tratamientos de enfermedades de la piel

- AlmirallShare lanza su quinta llamada para proposiciones, destinada a establecer asociaciones para encontrar nuevos acticos – nuevas entidades químicas, biológicas y otras terapias avanzadas – para el tratamiento de las condiciones dermatológicas - Los científicos podrán participar...

Almirall calls for collaborative innovation to advance new treatments for skin diseases

BARCELONA, Spain, July 22, 2020 /PRNewswire/ -- AlmirallShare, the open innovation platform of Almirall, S.A. (ALM), launches its fifth call, aiming to establish collaborations in dermatological research and identify new treatments for skin health. The call seeks partnering opportunities...

Acuerdo entre WuXi Biologics y Almirall relativo a anticuerpos biespecíficos para enfermedades dermatológicas

- WuXi Biologics y Almirall firman un acuerdo de colaboración estratégica para múltiples anticuerpos biespecíficos dirigidos a enfermedades dermatológicas La 12ª colaboración internacional de licencias para WuXiBody™ desde su lanzamiento en agosto de 2018, lo que muestra la potencia y las...

WuXi Biologics et Almirall signent un accord de collaboration stratégique pour de multiples anticorps bispécifiques ciblant les maladies dermatologiques

Le douzième partenariat mondial de licence pour WuXiBody™ depuis son lancement en août 2018, illustre la puissance et la polyvalence des applications de WuXiBody™ dans de multiples domaines thérapeutiques SHANGHAI et BARCELONE, Espagne, 9 janvier 2020 /PRNewswire/ -- WuXi Biologics («...

WuXi Biologics und Almirall unterzeichnen Vereinbarung über strategische Zusammenarbeit für mehrere bispezifische Antikörper zur Behandlung von Hauterkrankungen

Die 12. globale Lizenzpartnerschaft für WuXiBody™ seit Einführung der Plattform im August 2018 untermauert die Leistungsfähigkeit und vielseitigen Anwendungen von WuXiBody™ in verschiedenen therapeutischen Bereichen SCHANGHAI und BARCELONA, Spanien, 9. Januar 2020 /PRNewswire/ -- WuXi...

WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

The 12th global licensing partnership for WuXiBody™ since its launch in August 2018 showcasing the power and versatile applications of WuXiBody™ in multiple therapeutic areas SHANGHAI and BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading...
Show more

Almirall Frequently Asked Questions

  • When was Almirall founded?

    Almirall was founded in 1943.

  • Who are Almirall key executives?

    Almirall's key executives are Antonio Gallardo, Alfredo Barón de Juan and Gerhard Mayr.

  • How many employees does Almirall have?

    Almirall has 1,773 employees.

  • Who are Almirall competitors?

    Competitors of Almirall include Jazz Pharmaceuticals, Hikma Pharmaceuticals and Bausch Health Companies.

  • Where is Almirall headquarters?

    Almirall headquarters is located at 151 Ronda del General Mitre, Barcelona.

  • Where are Almirall offices?

    Almirall has an office in Barcelona.

  • How many offices does Almirall have?

    Almirall has 1 office.